Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double-blinded, randomised, controlled, phase 3b trial
2023 · EClinicalMedicine · 10 citations
https://doi.org/10.1016/j.eclinm.2023.102231